Literature DB >> 6688020

Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.

S M Rupp, M R Fahey, R D Miller.   

Abstract

The neuromuscular and cardiovascular effects of atracurium were compared during nitrous oxide-isoflurane and nitrous oxide-fentanyl anaesthesia in healthy surgical patients. The dose-response curve was shifted significantly to the left during nitrous oxide-isoflurane anaesthesia (ED50 0.068 mg kg-1) as compared with nitrous oxide-fentanyl anaesthesia (ED50 0.083 mg kg-1). For equipotent doses, the time course of neuromuscular effects (onset and duration) was not appreciably different between the nitrous oxide-isoflurane group and the nitrous oxide-fentanyl group. Minimal cardiovascular effects were observed from atracurium in doses up to 0.5 mg kg-1. Using comparisons from earlier studies, atracurium was approximately one-quarter as potent as pancuronium and vecuronium (Org NC 45). The onset time (time from injection to peak effect) for subparalytic doses of atracurium was approximately 6.5 min and is comparable to the onset time for equipotent doses of pancuronium and vecuronium. The duration of neuromuscular effects of atracurium (time from injection to 95% recovery) was approximately 20 min for subparalytic doses and is the same as that of vecuronium and one-third to one-half that of pancuronium. It is concluded that the peak effect of atracurium is enhanced more by nitrous oxide-isoflurane than by nitrous oxide-fentanyl anaesthesia, but for equipotent doses the time-course is the same.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688020

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  9 in total

Review 1.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

2.  Rapid tracheal intubation with atracurium--a comparison of priming intervals.

Authors:  M Naguib; H K Gyasi; M Abdulatif; G H Absood
Journal:  Can Anaesth Soc J       Date:  1986-03

Review 3.  The safe use of anaesthetics and muscle relaxants in older surgical patients.

Authors:  P M Lauven; J Nadstawek; S Albrecht
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

4.  Does vecuronium accumulate in the renal transplant patient?

Authors:  M A Starsnic; M E Goldberg; D E Ritter; A T Marr; M Sosis; G E Larijani
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

Review 5.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 6.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

7.  Quantifying the effect of enflurane on atracurium infusion requirements.

Authors:  M Kansanaho; K T Olkkola
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

8.  Atracurium versus vecuronium: a comparison of recovery in outpatient arthroscopy.

Authors:  W W Zuurmond; L van Leeuwen
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

9.  Neuromuscular blockade with atracurium besylate in a patient with myasthenia gravis.

Authors:  D F Murphy; J B Magner
Journal:  Ir J Med Sci       Date:  1986-06       Impact factor: 1.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.